BioSpace News Archive

IQVIA Report: Spending on Drugs Globally to Exceed $1.1 Trillion by 2024

Global medicine spending is projected to increase from 2 to 5% annually through 2024 on a net basis, compared to 4.2% in the past five years.

March 17, 2020
·
5 min read
·
Mark Terry
Biotech Bay

Cell Culture Protein Surface Coating Market Key Players Focus on R&D

A report by TMR Research, titled, “Cell Culture Protein Surface Coating Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” throws spotlight on the market.

March 17, 2020
·
3 min read
Pharm Country

Hospital Acquired Infection Treatment Market: High Susceptibility of Neonatal Population to Drive Market

Transparency Market Research has published a new report titled, ‘Hospital acquired infection treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

March 17, 2020
·
5 min read
Luck of the Irish: Recent Biopharma Successes to Come Out of Ireland

This St. Patrick’s Day, BioSpace takes a look at some of the most recent successes from four of Ireland’s most-noted companies.

March 17, 2020
·
5 min read
·
Alex Keown
Business

Pfizer and BioNTech to Develop mRNA Vaccine for COVID-19

The two companies will focus on BioNTech’s BNT162, an mRNA-based vaccine candidate.

March 17, 2020
·
3 min read
·
Alex Keown
Business

CureVac Chief Takes Non-Coronavirus Leave of Absence

There has been something of a furor over reports in the German newspaper Welt am Sonntag that claimed the Trump administration offered a “billion dollars” for exclusive rights to a coronavirus vaccine in development by German company CureVac, “but only for the USA.”

March 17, 2020
·
3 min read
·
Mark Terry
Business

Flatten the Curve: COVID-19

‘Flatten the Curve’ is sure to become a phrase forever linked with COVID-19. It refers to doing all we can as individuals to slow the spread of COVID-19 so that all available resources can be used for those who need them most urgently.

March 17, 2020
·
4 min read
·
Gina Hagler
Pharm Country

Dr. Reddy’s Laboratories announces the launch of Ziprasidone Mesylate for Injection in the U.S. Market

Dr. Reddy’s Laboratories Ltd. announced the launch of Ziprasidone Mesylate for Injection, 20 mg /mL Single-dose Vials, the therapeutic generic equivalent of Geodon® Injection, 20 mg/mL, approved by the U.S. Food and Drug Administration.

March 17, 2020
·
3 min read
BioMidwest

Embold Health Brings Top Sales Professional on Board as SVP of Sales

Susan Thomson joins the Embold Health team bringing 25+ years of sales experience in several key healthcare and insurance sectors.

March 17, 2020
·
2 min read
BioMidwest

Steward Health Care’s System-Wide Approach To COVID-19 Includes Enhanced Remote Testing Centers, Reinforced Community Hospital Services, And Nation’s First “Dedicated Care Center” To Only Treat COVID-19 Patients

Steward Health Care has taken a very systematic, proactive and comprehensive approach to balance the need of accommodating a rise in COVID-19 patients, while maintaining the level and quality of care for all our patients and the communities we serve.

March 17, 2020
·
4 min read